The pandemic has brought seismic changes to the pharmacy industry. And the second year of the pandemic has brought new obstacles and uncertainties, adding to the challenges that already exist for pharmacy, including DIR fees, declining reimbursement and the requirement to quickly fill a higher volume of prescriptions.
Yet, despite these daunting challenges, the industry has been outperforming. As we bid adieu to a year that played havoc with expectations and look forward to the pandemic fading in the rearview mirror, the role of the pharmacist and pharmacies has never been more crucial.
DSN asked several pharmacy industry executives and those who provide products and services to pharmacies to weigh in on the state of the pharmacy business. Their answers illustrate that the glass is indeed half full.